著者
加藤 隆弘 兵藤 文紀 大和 真由実 内海 英雄 神庭 重信
出版者
公益社団法人 日本薬学会
雑誌
YAKUGAKU ZASSHI (ISSN:00316903)
巻号頁・発行日
vol.135, no.5, pp.739-743, 2015 (Released:2015-05-01)
参考文献数
36
被引用文献数
2 1

Altered antioxidant status has been implicated in schizophrenia. Microglia are major sources of free radicals such as superoxide in the brain, and play crucial roles in various brain diseases. Recent postmortem and imaging studies have indicated microglial activation in the brain of schizophrenia patients. Animal models that express some phenotypes of schizophrenia have revealed the underlying microglial pathology. In addition, minocycline, an antibiotic and the best known inhibitor of microglial activation, has therapeutic efficacy in schizophrenia. We have recently revealed that various antipsychotics directly affect microglia via proinflammatory reactions such as oxidative stress, by in vitro studies using rodent microglial cells. Based on these findings, we have suggested that microglia are crucial players in the brain in schizophrenia, and modulating microglia may be a novel therapeutic target. In this review paper, we introduce our hypothesis based on the above evidence. The technique of in vivo molecular redox imaging is expected to be a powerful tool to clarify this hypothesis.

言及状況

外部データベース (DOI)

Twitter (2 users, 2 posts, 5 favorites)

統合失調症の病態治療機構におけるレドックスとミクログリア 加藤隆弘@KyushuUniv_JP 2015年 …さらに,最もよく知られている活性化ミクログリアの抑制剤である抗生物質ミノサイクリンは,統合失調症において治療効果を有する. https://t.co/YSFiBD8oXw

収集済み URL リスト